OTINYAJECT Trademark

Trademark Overview

On Friday, September 25, 2015, a trademark application was filed for OTINYAJECT with the United States Patent and Trademark Office. The USPTO has given the OTINYAJECT trademark a serial number of 86769199. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2019. This trademark is owned by Novartis AG. The OTINYAJECT trademark is filed in the Medical Instrument Products category with the following description:

Injection device for pharmaceuticals
otinyaject

General Information

Serial Number86769199
Word MarkOTINYAJECT
Filing DateFriday, September 25, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2015

Trademark Statements

Goods and ServicesInjection device for pharmaceuticals
Pseudo MarkO TINY AJECT; ONE TINY INJECTION

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 1, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, March 18, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 8, 2018EXTENSION 5 GRANTED
Tuesday, July 31, 2018EXTENSION 5 FILED
Wednesday, August 8, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 31, 2018TEAS EXTENSION RECEIVED
Friday, February 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2018EXTENSION 4 GRANTED
Wednesday, February 7, 2018EXTENSION 4 FILED
Wednesday, February 7, 2018TEAS EXTENSION RECEIVED
Tuesday, August 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 29, 2017EXTENSION 3 GRANTED
Saturday, July 29, 2017EXTENSION 3 FILED
Saturday, July 29, 2017TEAS EXTENSION RECEIVED
Saturday, February 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 9, 2017EXTENSION 2 GRANTED
Thursday, February 9, 2017EXTENSION 2 FILED
Thursday, February 9, 2017TEAS EXTENSION RECEIVED
Tuesday, January 24, 2017ASSIGNED TO EXAMINER
Tuesday, August 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 7, 2016EXTENSION 1 GRANTED
Sunday, August 7, 2016EXTENSION 1 FILED
Sunday, August 7, 2016TEAS EXTENSION RECEIVED
Tuesday, February 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 11, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 9, 2015ASSIGNED TO EXAMINER
Friday, October 2, 2015NOTICE OF PSEUDO MARK E-MAILED
Thursday, October 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 29, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

otinyaject pharmaceuticals device injection